Skip to main navigation Skip to search Skip to main content

Prominent asymmetric muscle weakness and atrophy in seronegative immune-mediated necrotizing myopathy

  • The Catholic University of Korea Incheon St. Mary's Hospital

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Immune-mediated necrotizing myopathy, a new subgroup of inflammatory myopathies, usually begins with subacute onset of symmetrical proximal muscle weakness. A 35-year-old male presented with severe asymmetric iliopsoas atrophy and low back pain with a previous history of left lower extremity weakness. Although his first left lower extremity weakness occurred 12 years ago, he did not receive a clear diagnosis. Magnetic resonance imaging of both thigh muscles showed muscle edema and contrast enhancement in patch patterns, and the left buttock and thigh muscles were more atrophied compared to the right side. Serum creatine kinase levels were elevated, and serologic testings were all negative. Genetic testing using a targeted gene-sequencing panel for neuromuscular disease including myopathy identified no pathogenic variants. Muscle biopsy on the right vastus lateralis showed scattered myofiber necrosis with phagocytosis and an absence of prominent inflammatory cells, consistent with seronegative necrotizing myopathy. Thus, unusual asymmetric muscle weakness and atrophy can be a manifestation of inflammatory myopathy.

Original languageEnglish
Article number2064
JournalDiagnostics
Volume11
Issue number11
DOIs
StatePublished - Nov 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

  • Asymmetric muscle involvement
  • Immune-mediated necrotizing myopathy
  • Inflammatory myopathy

Fingerprint

Dive into the research topics of 'Prominent asymmetric muscle weakness and atrophy in seronegative immune-mediated necrotizing myopathy'. Together they form a unique fingerprint.

Cite this